Skip Navigation

European Heart Journal 1992 13(1):28-32;
Copyright © 1992 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by OLSSON, G.
Right arrow Articles by SONNENBLICK, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OLSSON, G.
Right arrow Articles by SONNENBLICK, E. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 The European Society of Cardiology

Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials

G. OLSSON*,, J. WIKSTRAND{dagger}, I. WARNOLD{ddagger}, V. MANGER CATS§, D. MCBOYLE||, J. HERLITZ, Å. HJALMARSON and E. H. SONNENBLICK**

*Department of Medicine, Karolinska Institutet, Danderyd Hospital Danderyd, Sweden
{dagger}Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Hospital, Gothenburg University Göteborg, Sweden
{ddagger}Hässle Research Laboratories Mölndal, Sweden
§Department of Cardiology, Academisch Ziekenhuis Leiden Leiden, Netherlands
||Department of Cardiology, The Ulster Hospital Belfast, Ireland
Department of Medicine, Sahlgrenska Hospital Göteborg, Sweden
**Division of Cardiology, Albert Einstein College of Medicine Bronx, N.Y., U.S.A.

Received 20 April 1990; revised 19 November 1990; .

Correspondence Gunnar Olssan, MD.PhD

Abstract

Several postinfarction trials have evaluated the effect of secondary prophylaxis with different beta-blockers. Although so called meta-analysis of the results from all the trials have shown a beneficial effect of postinfarction beta-blockade, many of the individual studies have shown inconclusive results, mainly due to low statistical power. In order to obtain an evaluation of the merits of postinfarction therapy with metoprolol, data from the five available studies with metoprolol have been pooled into one database. In the total material 5474 patients (4353 men, 1121 women) have been studied during double-blind therapy with metoprolol 100 mg twice daily or matching placebo. The follow-up time ranges from 3 months to 3 years. In total 4732 patient years of observation have been obtained.

In total there were 223 deaths in the placebo-treated patients as compared to 188 deaths in the metoprolol-treated patients (P = 0.036), which corresponds to mortality rates of 97.0 and 78.3 per 1000 patient years, respectively. The mortality reduction was found both in men and women. As has been reported from individual postinfarction beta-blocker trials, the pooled results showed a marked reduction in sudden deaths (104 in the placebo group, 62 in the metoprolol group, P = 0.002). In a Cox regression model the influence of sex, age and smoking habits on the effect of metoprolol was evaluated. None of these factors influenced the metoprolol effect signficantly.

It is concluded that metoprolol therapy after acute myocardial infarction reduces the total number of deaths, and especially sudden cardiac deaths. The mortality reduction was independent of gender, age and smoking habits. A vailable data support a continuous beneficial effect.

Key Words: Metoprolol • postinfarction • mortality


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. K. Lahiri, P. J. Kannankeril, and J. J. Goldberger
Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications.
J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1725 - 1733.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
N. Jochmann, K. Stangl, E. Garbe, G. Baumann, and V. Stangl
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases
Eur. Heart J., August 2, 2005; 26(16): 1585 - 1595.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
E. Marret and P. Albaladejo
Are {beta}-Blockers Useful to Protect High-Risk Patients Scheduled for Open Cholecystectomy?
Arch Intern Med, February 14, 2005; 165(3): 348 - 348.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
M. J Everly, P. C Heaton, and R. J Cluxton Jr
{beta}-Blocker Underuse in Secondary Prevention of Myocardial Infarction
Ann. Pharmacother., February 1, 2004; 38(2): 286 - 293.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Steendijk, S. A. F. Tulner, J. J. Schreuder, J. J. Bax, L. van Erven, E. E. van der Wall, R. A. E. Dion, M. J. Schalij, and J. Baan
Quantification of left ventricular mechanical dyssynchrony by conductance catheter in heart failure patients
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H723 - H730.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. H. D. Danton, G. F. Greil, J. G. Byrne, M. Hsin, L. Cohn, and S. E. Maier
Right ventricular volume measurement by conductance catheter
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1774 - H1785.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
P. W. C. ten Broecke, S. G. De Hert, E. Mertens, and H. F. Adriaensen
Effect of preoperative {beta}-blockade on perioperative mortality in coronary surgery
Br. J. Anaesth., January 1, 2003; 90(1): 27 - 31.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Z Abildstrom, C Rask-Madsen, M M Ottesen, P K Andersen, S Rosthoj, C Torp-Pedersen, and L Kober
Impact of age and sex on sudden cardiovascular death following myocardial infarction
Heart, December 1, 2002; 88(6): 573 - 578.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Cataliotti, G. Boerrigter, H. H. Chen, M. Jougasaki, L. C. Costello, T. Tsuruda, S.-C. Lee, L. S. Malatino, and J. C. Burnett Jr
Differential Actions of Vasopeptidase Inhibition Versus Angiotensin-Converting Enzyme Inhibition on Diuretic Therapy in Experimental Congestive Heart Failure
Circulation, February 5, 2002; 105(5): 639 - 644.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
O. Wiklund, J. Hulthe, J. Wikstrand, C. Schmidt, S.-O. Olofsson, and G. Bondjers
Effect of Controlled Release/Extended Release Metoprolol on Carotid Intima-Media Thickness in Patients With Hypercholesterolemia: A 3-Year Randomized Study
Stroke, February 1, 2002; 33(2): 572 - 577.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Haloui, D. Messika-Zeitoun, L. Louedec, M. Philippe, and J.-B. Michel
Potentiation of urinary atrial natriuretic peptide interferes with macula densa function
Cardiovasc Res, August 15, 2001; 51(3): 542 - 552.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Steendijk, E. Staal, J. W. Jukema, and J. Baan
Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter
Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H755 - H763.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L Kornet, J.J Schreuder, E.T van der Velde, J Baan, and J.R.C Jansen
A new approach to determine parallel conductance for left ventricular volume measurements
Cardiovasc Res, December 1, 2000; 48(3): 455 - 463.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Kuhlkamp, A. Schirdewan, K. Stangl, M. Homberg, M. Ploch, and O. A. Beck
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Med. Inform. Assoc.Home page
H. P. Lehmann and S. N. Goodman
Bayesian Communication: A Clinically Significant Paradigm for Electronic Publication
J. Am. Med. Inform. Assoc., May 1, 2000; 7(3): 254 - 266.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
P. Steendijk and J. Baan
Comparison of intravenous and pulmonary artery injections of hypertonic saline for the assessment of conductance catheter parallel conductance
Cardiovasc Res, April 1, 2000; 46(1): 82 - 89.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
R. D. Feldman, N. Campbell, P. Larochelle, P. Bolli, E. D. Burgess, S. G. Carruthers, J. S. Floras, R. B. Haynes, G. Honos, F. H.H. Leenen, et al.
1999 Canadian recommendations for the management of hypertension
Can. Med. Assoc. J., December 14, 1999; 161(90120): S1 - 17.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
H. V. Barron, S. Viskin, R. J. Lundstrom, B. E. Swain, A. F. Truman, C. C. Wong, and J. V. Selby
{beta}-Blocker Dosages and Mortality After Myocardial Infarction: Data From a Large Health Maintenance Organization
Arch Intern Med, March 9, 1998; 158(5): 449 - 453.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. E. Schmidt Jr, M. J. MacDonald, C. O. Murphy, W. M. Brown III, J. P. Gott, and R. A. Guyton
Leukocyte Depletion of Blood Cardioplegia Attenuates Reperfusion Injury
Ann. Thorac. Surg., December 1, 1996; 62(6): 1691 - 1696.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.